Zobrazeno 1 - 10
of 145
pro vyhledávání: '"Tsutomu, Kawaguchi"'
Autor:
Kazuki Moro, Masayuki Nagahashi, Kotaro Hirashima, Shin-ichi Kosugi, Takaaki Hanyu, Hiroshi Ichikawa, Takashi Ishikawa, Gen Watanabe, Emmanuel Gabriel, Tsutomu Kawaguchi, Kazuaki Takabe, Toshifumi Wakai
Publikováno v:
Surgical Case Reports, Vol 3, Iss 1, Pp 1-6 (2017)
Abstract Background Benign esophageal tumors are uncommon, comprising approximately 2% of esophageal tumors. Esophageal schwannomas constitute an even rarer entity, with few cases reported in the literature. Case presentation We present a 66-year-old
Externí odkaz:
https://doaj.org/article/ac3a5d2a5f5749b4a6821d7f0fde933d
Autor:
Kazuki Moro, Masayuki Nagahashi, Tetsuya Naito, Yu Nagai, Tomohiro Katada, Masahiro Minagawa, Jun Hasegawa, Tatsuo Tani, Naohiro Shimakage, Hiroyuki Usuda, Emmanuel Gabriel, Tsutomu Kawaguchi, Kazuaki Takabe, Toshifumi Wakai
Publikováno v:
Surgical Case Reports, Vol 3, Iss 1, Pp 1-6 (2017)
Abstract Background A gastric adenosquamous carcinoma (ASC) that produces granulocyte-colony stimulating factor (G-CSF) is an uncommon malignancy with a poor prognosis. Due to the rarity of this lesion, a standard treatment for the disease has not be
Externí odkaz:
https://doaj.org/article/dc63c22bc79b449cb69ed9c69f80f6c3
Autor:
Jan-Stefan van der Walt, Joji Mori, Takahiro Nakayama, Kenichi Inoue, Yoshinori Ito, George W. Sledge, Yasuo Miyoshi, Tsutomu Kawaguchi, Masato Takahashi, Yoshinori Tanizawa, Masakazu Toi, Antonio Llombart-Cussac, Norikazu Masuda, Hiroji Iwata, Hirofumi Mukai, Sachi Sakaguchi
Publikováno v:
Breast Cancer (Tokyo, Japan)
Background This was a Japanese subpopulation analysis of MONARCH 2, a double-blind, randomized, placebo-controlled, phase 3 study of abemaciclib plus fulvestrant in patients with hormone receptor-positive, human epidermal growth factor receptor 2-neg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c71f889661f19ce20b881eac8a2ec03f
http://hdl.handle.net/2433/277491
http://hdl.handle.net/2433/277491
Autor:
Tsutomu Kawaguchi, Shuhei Komatsu, Daisuke Ichikawa, Shoji Hirajima, Yukihisa Nishimura, Hirotaka Konishi, Atsushi Shiozaki, Hitoshi Fujiwara, Kazuma Okamoto, Hitoshi Tsuda, Eigo Otsuji
Publikováno v:
Tumor Biology, Vol 39 (2017)
Recent studies have shown that some members of the tripartite motif-containing protein family function as important regulators for carcinogenesis. In this study, we investigated whether tripartite motif-containing protein 44 acts as a cancer-promotin
Externí odkaz:
https://doaj.org/article/e42d0e88bb75497c80e09b858ea46596
Autor:
Masaaki Kawai, Masahiro Takada, Takahiro Nakayama, Norikazu Masuda, Hirokazu Shiheido, Zhihong Cai, Yu-Jing Huang, Tsutomu Kawaguchi, Yoshinori Tanizawa
Publikováno v:
Breast cancer research and treatment. 197(2)
Purpose The aim was to understand real-world cyclin-dependent kinase (CDK) 4 and 6 inhibitor use in Japan. Methods This retrospective observational study used a Japanese administrative claims database and included patients with presumptive hormone re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ea6d94a40c397aabf7b303d7e35bf16
https://pubmed.ncbi.nlm.nih.gov/36414795
https://pubmed.ncbi.nlm.nih.gov/36414795
Autor:
Hiroki Shimizu, Hideo Takahashi, Tomohiro Arita, Atsushi Shiozaki, Hisashi Ikoma, Yusuke Yamamoto, Allan Tsung, Eigo Otsuji, Hiroyuki Inoue, Hitoshi Fujiwara, Tsutomu Kawaguchi, Ryo Morimura, Kazuma Okamoto, Takeshi Kubota, Yoshiaki Kuriu, Toshiya Ochiai, Kazuaki Takabe, Hirotaka Konishi
Publikováno v:
Journal of Surgical Oncology. 124:791-800
BACKGROUND Oligometastasis, the presence of a small number of resectable metastatic tumors, usually has favorable outcomes. Here we examined whether the novel oligometastatic score (OLGS), which divides the number of colorectal liver metastases (CRLM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e9ed17dd603d454d057f93cdd82e623
https://doi.org/10.1002/jso.26575
https://doi.org/10.1002/jso.26575
Autor:
Katsuharu Saito, Ichiro Okano, Ali Linsk Butash, Koji Kono, Kazuaki Takabe, Masayuki Nagahashi, Tsutomu Kawaguchi, Maiko Okano, Masanori Oshi, Toru Ohtake
Publikováno v:
J Mammary Gland Biol Neoplasia
BACKGROUND: Patient-Derived Xenograft (PDX) is now accepted as a murine model that better mimics human cancer when compared to a conventional cancer cell-line inoculation model. Some claim the advantage of orthotopic site implantation of patient tumo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::272935205ef58e699fdf8314bcc39bac
https://doi.org/10.1007/s10911-020-09442-7
https://doi.org/10.1007/s10911-020-09442-7
Autor:
Pan Xu, Li Yan, Maiko Okano, Aparna Maiti, Tsutomu Kawaguchi, Kazuaki Takabe, Nitai C. Hait, Qianya Qi, Cheng Luo
Publikováno v:
FASEB J
Sphingosine kinase 2 (SphK2) is known to phosphorylate the nuclear sphingolipid metabolite to generate sphingosine-1-phosphate (S1P). Nuclear S1P is involved in epigenetic regulation of gene expression; however, the underlying mechanisms are not well
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6348e82b97b4da6235e3430f969f0ad3
https://doi.org/10.1096/fj.201901734rr
https://doi.org/10.1096/fj.201901734rr
Publikováno v:
Cancer Management and Research.
Norikazu Masuda,1 Yucherng Chen,2 Tsutomu Kawaguchi,3 Koji Dozono,4 Masakazu Toi5 1Department of Breast and Endocrine Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan; 2Safety Science, Quality and Patient Safety, Eli Lilly Japan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6263e71c0ebd5947e797214d6f17a83
https://www.dovepress.com/safety-in-japanese-advanced-breast-cancer-patients-who-received-abemac-peer-reviewed-fulltext-article-CMAR
https://www.dovepress.com/safety-in-japanese-advanced-breast-cancer-patients-who-received-abemac-peer-reviewed-fulltext-article-CMAR
Publikováno v:
Cancer Research. 83:P5-02
Background: Pretreatment neutrophil-to-lymphocyte ratio (NLR) and absolute lymphocyte count (ALC) are putative prognostic factors in patients with advanced breast cancer (ABC). Little information is available on the prognostic value of these immune s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7de723c49741961f6f9f20ba047d41ec
https://doi.org/10.1158/1538-7445.sabcs22-p5-02-23
https://doi.org/10.1158/1538-7445.sabcs22-p5-02-23